Chesnara (CSN) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
24 Mar, 2026Executive summary
Achieved significant strategic transformation through major M&A activity, including the acquisition of HSBC Life UK (now Chesnara Life) and restructuring in the Dutch business.
Announced the acquisition of Scottish Widows Europe, expected to add EUR 250 million in lifetime cash flows, with integration and regulatory approval processes underway.
Delivered strong financial results across all key metrics, with increased new business contributions and robust operating performance.
Maintained a robust balance sheet, entered the FTSE 250 for the first time, and raised significant capital through rights issue and RT1 bond.
Continued commitment to sustainability, publishing the first Climate Transition Plan and expanding social impact activities.
Financial highlights
Operating capital generation rose 19% year-over-year to GBP 94 million.
Adjusted operating profit up 42% to GBP 56 million; cash remittances increased to GBP 58 million.
Own funds increased 34% to GBP 859 million, driven by capital raises and operational performance.
Solvency II coverage ratio rose to 257%, up 54 percentage points year-over-year.
Assets under administration grew to GBP 15 billion, expected to exceed GBP 20 billion post-M&A.
Final dividend increased 6% to GBP 0.148 per share.
Outlook and guidance
Focus for 2026 includes integration of Chesnara Life, change of control for Scottish Widows Europe SA, balance sheet optimization, and new M&A opportunities.
Pro forma own funds projected to exceed GBP 1 billion after Chesnara Life integration.
Anticipate near doubling of new business value in 2026 following recent M&A.
2026 interim dividend expected to rise by a further 6%, representing a one-off acceleration in dividend growth.
Continued delivery of decarbonisation activities in line with the Climate Transition Plan.
Latest events from Chesnara
- Simplified metrics highlight sustainable capital and profit, enhancing transparency and comparability.CSN
Investor presentation16 Mar 2026 - €110m Luxembourg deal adds €1.7bn assets, €250m cash, and boosts European expansion.CSN
M&A announcement17 Feb 2026 - Strong cash generation, 3% dividend rise, and 201% solvency with active M&A pipeline.CSN
H1 20243 Feb 2026 - Cash generation up 14%, solvency at 203%, and dividend up 3% with strong M&A momentum.CSN
H2 202426 Dec 2025 - £37m cash generation, 207% solvency, and HSBC Life (UK) acquisition drive growth.CSN
H1 202523 Nov 2025 - £260m deal, £140m rights issue, £800m+ cash flow, 6% dividend growth, FTSE 250 target.CSN
M&A Announcement13 Nov 2025